Overview

Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
This is a phase 4, multi-centre, randomized, two group, open label, active controlled, parallel group, 17 week trial.
Phase:
Phase 4
Details
Lead Sponsor:
LEO Pharma
Treatments:
Diclofenac